Cue Biopharma in $374M-plus Merck immunotherapy pact – FierceBiotech
FierceBiotech |
Cue Biopharma in $374M-plus Merck immunotherapy pact
FierceBiotech After raising $26 million at the start of the year, cancer and autoimmune startup Cue Biopharma has ended the year with a potentially lucrative new deal with Merck. Financial details are patchy, but we know the Big Pharma could pay up to $374 million … Cue Biopharma Announces Strategic Research Collaboration and License Agreement with Merck |
